Surgical Stents Market Research Report By Product Type (Coronary Stents, Peripheral Stents, Biliary Stents, Urological Stents, Gastrointestinal Stents), By Material (Metal Stents, Polymer Stents, Bioabsorbable Stents, Coated Stents), By End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Delivery Method (Balloon-Expandable Stents, Self-Expanding Stents), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Surgical Stents Market Summary

As per MRFR analysis, the Surgical Stents Market was valued at 5.79 USD Billion in 2023 and is projected to grow to 10.2 USD Billion by 2035, reflecting a CAGR of 4.82% from 2025 to 2035. The market is driven by advancements in healthcare technology, increasing prevalence of chronic diseases, and an aging population, leading to a higher demand for surgical stents across various medical procedures.

Key Market Trends & Highlights

Key trends driving the Surgical Stents Market include technological advancements and demographic shifts.

• Coronary Stents are expected to grow from 2.5 USD Billion in 2024 to 4.2 USD Billion by 2035.
• The geriatric population is projected to reach 2 billion by 2050, increasing demand for surgical stents.
• Healthcare spending is rising globally, with some countries investing nearly 10% of GDP in healthcare infrastructure.
• Innovations like drug-eluting and biodegradable stents are enhancing patient outcomes and reducing recovery times.

Market Size & Forecast

2023 Market Size: USD 5.79 Billion

2024 Market Size: USD 6.07 Billion

2035 Market Size: USD 10.2 Billion

CAGR (2025-2035): 4.82%

Largest Regional Market Share in 2024: North America

Major Players

Key players include Endo International, Abbott Laboratories, Boston Scientific, Medtronic, and Cook Medical.

Key Surgical Stents Market Trends Highlighted

The growing incidence of chronic illnesses, an aging population, and improvements in stent technology are some of the major factors propelling the Surgical Stents Market. Global demand for surgical stents is being driven by an increase in the prevalence of gastrointestinal ailments, urinary tract disorders, and cardiovascular diseases.

Manufacturers of medical devices are coming out with new, safer, and more effective stent solutions in response to these health issues, which will improve patient outcomes. There are opportunities to investigate, such as diversifying into developing nations with developing healthcare systems.

The need for surgical stents is rising in Latin American and Asia-Pacific nations as a result of improved access to healthcare and more knowledge of less invasive therapeutic alternatives. Additionally, collaborations between stent producers and healthcare providers may improve product availability and distribution, opening up new markets for the product.

The development of drug-eluting and bioresorbable stents, which reduce the risk of problems and speed up recovery, has become more popular in recent years. This trend toward innovation is further supported by the use of cutting-edge materials that lower thrombosis rates, such as metals and polymer mixes.

Furthermore, it is increasingly common to integrate digital health for improved patient management and monitoring during stent treatments. This development demonstrates how the global market for surgical stents has adjusted to the changing demands of healthcare systems while striving for better patient care and treatment effectiveness.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Surgical Stents Market Drivers

Increasing Prevalence of Cardiovascular Diseases

The Surgical Stents Market is significantly driven by the rising prevalence of cardiovascular diseases worldwide. According to the World Health Organization, cardiovascular diseases account for 32 percent of all global deaths each year, highlighting an increasing number of patients requiring surgical intervention.For instance, the American Heart Association has reported that about 697,000 deaths in the United States alone in 2020 were attributed to heart diseases. This emphasizes the critical need for effective surgical interventions, including stenting procedures.

Moreover, technological advancements and improved training of healthcare professionals in performing stenting procedures, backed by organizations like the European Society of Cardiology, are enhancing patient outcomes and driving the market growth. As healthcare systems globally emphasize preventative care and intervention measures, the demand for surgical stents is expected to rise accordingly.

Technological Advancements in Stents

Another significant driver for the Surgical Stents Market is the rapid technological advancements in stent design and materials. The development of bioresorbable stents, which dissolve over time, has garnered extensive attention from healthcare providers due to improved patient outcomes and reduced long-term complications.The Food and Drug Administration has approved several innovative stent systems in recent years, which has led to increased adoption among healthcare providers.

Furthermore, the integration of advanced materials and coatings that reduce re-stenosis rates has made stenting procedures safer and more effective. This surge in technological progress, spearheaded by leading medical device manufacturers, is expected to propel market growth significantly.

Growing Geriatric Population

The increasing geriatric population globally is a major driver for the Surgical Stents Market. According to the United Nations, by 2050, the number of individuals aged 60 years or over is projected to reach 2.1 billion, up from 1 billion in 2019.This demographic shift is expected to lead to a higher prevalence of chronic diseases, including those requiring stenting procedures. 

The aging population often suffers from multiple co-morbidities, which necessitate complex interventions such as stenting.Health organizations worldwide are focusing on elder care and improving healthcare infrastructure to cater to this growing population, thereby driving the demand for surgical stents.

Increase in Healthcare Expenditure

Global healthcare expenditure has been on the rise, a trend that notably impacts the Surgical Stents Market. According to the World Bank, global health expenditure increased from 8.6 percent of GDP in 2000 to 10.0 percent in 2019.This increase allows for better access to modern medical technologies, including surgical stents. 

Governments and private sectors are investing heavily in healthcare facilities, leading to improved surgical care and the rise of stenting procedures.Countries like Germany and the United States have been at the forefront of healthcare investments, leading to enhanced service delivery and increased demand for surgical stents as part of strategic health initiatives.

Surgical Stents Market Segment Insights

Surgical Stents Market Product Type Insights

The Surgical Stents Market, particularly within the product type segment, was poised for significant revenue growth. The market was segmented into various categories including coronary stents, peripheral stents, biliary stents, urological stents, and gastrointestinal stents, each contributing uniquely to the overall market landscape.

The majority holding in this market came from Coronary Stents, valued at 2.53 USD Billion in 2024 and projected to reach 4.21 USD Billion by 2035. This dominance was attributed to the rising prevalence of cardiovascular diseases, which necessitate effective intervention methods like stenting.

Peripheral Stents followed, holding a significant market value of 1.43 USD Billion in 2024, and an anticipated rise to 2.42 USD Billion by 2035. Their importance stemmed from increasing incidences of peripheral artery diseases and the need for vascular interventions that preserve limb functionality.

Biliary Stents, valued at 0.74 USD Billion in 2024 and rising to 1.25 USD Billion by 2035, catered to patients with obstructive jaundice, thus highlighting their crucial role in managing biliary complications related to various cancers and liver diseases.Urological Stents, which held a market value of 0.92 USD Billion in 2024 and are projected to grow to 1.55 USD Billion by 2035, are essential in treating ureteral obstructions and managing urinary conditions, being integral in both emergency and elective procedures.

Gastrointestinal Stents, while smaller in comparison with a valuation of 0.45 USD Billion in 2024 and expected to grow to 0.77 USD Billion by 2035, also fulfilled a vital function in relieving obstructions within the gastrointestinal tract, often linked with cancer or inflammatory diseases.

The overall trends within the Surgical Stents Market were shaped by technological advancements, rising surgical procedures, and a growing awareness of minimally invasive treatments. This sector faced challenges such as regulatory hurdles and the risk of complications from stent placement, yet opportunities beckon in the form of innovative materials and expanding applications.

The Surgical Stents Market data illustrated a sector that is not only growing in financial terms but is also pivotal to improving patient outcomes globally. The global focus on healthcare access and quality bolsters the significance of these devices, ensuring that the demand continues to rise in both developed and emerging markets.Thus, understanding the intricacies of this market segmentation unveiled the critical role surgical stents played in contemporary medical practice, highlighting their importance in enhancing the quality of patient care.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Surgical Stents Market Material Insights

The market is characterized by a diverse range of materials used in the development of surgical stents, which include Metal Stents, Polymer Stents, Bioabsorbable Stents, and Coated Stents. Metal stents have been widely utilized due to their durability and strength, making them significant in many surgical applications.

Polymer stents offer versatility and less weight, while bioabsorbable stents are gaining traction for their ability to dissolve over time, minimizing long-term complications. Coated stents enhance biocompatibility, further supporting the growing trend towards personalized medicine.

The Surgical Stents Market data reflects a shift in preference towards these technologically advanced materials, driven by factors such as rising prevalence of cardiovascular diseases and advancements in medical technology.As the market continues to grow, driven by shifts in demographics and increasing health expenditure globally, these material types are expected to play pivotal roles in addressing the surgical needs of patients effectively.

Surgical Stents Market End-user Insights

The Surgical Stents Market is experiencing diverse growth across its End-user segment, which primarily includes Hospitals, Ambulatory Surgical Centers, and Specialty Clinics. Hospitals remain a key player in the market, holding a significant share due to their capacity to handle complex surgeries and comprehensive healthcare services.

Ambulatory Surgical Centers have gained traction as they offer cost-effective solutions and convenience to patients, catering to outpatient procedures that typically demand quicker recovery times. Specialty Clinics are also important, specializing in specific areas such as cardiology and urology, thus addressing targeted patient needs effectively.The market growth within these End-users is spurred by rising incidences of chronic diseases and the need for minimally invasive surgery options.

Additionally, favorable reimbursement policies and increasing healthcare expenditure globally serve as catalysts for this segment, creating ample opportunities while also posing challenges like regulatory compliance and market competition across the surgical domain. Overall, the Surgical Stents Market segmentation indicates a strong outlook bolstered by these diverse yet crucial End-users.

Surgical Stents Market Delivery Method Insights

The Surgical Stents Market, particularly in the Delivery Method segment, is showing notable growth as it evolves to meet increasing patient needs and advances in medical technology. Within this segment, Balloon-Expandable Stents and Self-Expanding Stents play critical roles, with the former being widely utilized in various interventional procedures due to their ability to adapt in specific anatomical settings.Self-Expanding Stents, on the other hand, provide advantages in treating challenging areas, ensuring consistent support within the targeted vessels. The rising prevalence of cardiovascular diseases and increasing surgical procedures are driving the demand for these stents globally.

Market statistics reveal that the sector is evolving with trends such as improving material technologies and minimally invasive techniques, which enhance patient recovery times and outcomes. However, challenges do exist, including regulatory hurdles and cost factors, which influence market dynamics.Overall, the Surgical Stents Market data indicates a robust landscape with continuous opportunities for innovation and growth in the Delivery Method segment, thus shaping the industry’s future.

Surgical Stents Market Regional Insights

The Surgical Stents Market presented a diverse landscape across its regional segmentation. North America dominated the market with a valuation of 2.5 USD Billion in 2024 and is expected to reach 4.1 USD Billion by 2035, largely due to its advanced healthcare infrastructure and high adoption of innovative medical technologies.Europe followed, with a valuation of 1.8 USD Billion in 2024, growing to 2.9 USD Billion by 2035, driven by increasing cardiovascular disease prevalence and regulatory support for medical devices. Asia Pacific held a notable position, also valued at 1.8 USD Billion in 2024 and anticipated to match Europe by 2035, reflecting rapid urbanization and an increasing geriatric population.

South America was valued at 0.5 USD Billion in 2024, growing to 0.8 USD Billion by 2035, indicating a moderate yet emerging market driven by improved healthcare access. The Middle East and Africa, although valued at 0.47 USD Billion in 2024, showed potential for growth, with an increase to 0.6 USD Billion in 2035, as healthcare investments rose in response to growing health concerns.These insights underlined the varied growth trajectories within the Surgical Stents Market and highlighted North America as a major player while pointing to significant opportunities in emerging markets.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Surgical Stents Market Key Players and Competitive Insights

The Surgical Stents Market is characterized by a diverse range of stakeholders, including multinational corporations, regional players, and niche innovators. The competition in this market is intensified by the continuous advancements in technology, along with the rising demand for minimally invasive surgical procedures globally.

Companies in this sector are constantly working on developing innovative solutions to enhance patient outcomes and reduce recovery times. This dynamic nature of the market has led to strategic partnerships, mergers, and collaborations as players strive to maintain their competitive edge and expand their market share.

Regulatory approvals and clinical outcomes also play a critical role in shaping the competitive landscape, as they influence not only product offerings but also market entry strategies for new entrants.MicroPort Scientific stands out in the Surgical Stents Market due to its strong focus on innovation and quality. The company has developed a robust portfolio of surgical stents that address various medical needs, showcasing its commitment to improving patient care and outcomes.

MicroPort Scientific has made strategic investments in research and development, empowering it to introduce cutting-edge technologies that enhance the functionality and effectiveness of stents. The company is also known for its strong distribution network globally, allowing it to reach various healthcare providers and patients efficiently.

This extensive market presence is complemented by a reputation for high-quality manufacturing standards, which bolsters customer confidence and brand loyalty within the competitive landscape.Stentys has carved out a significant niche in the Surgical Stents Market with its focus on innovative solutions targeted primarily at cardiovascular conditions. The company is recognized for its specialized stent offerings, including self-expanding stents that address the unique challenges faced during percutaneous coronary interventions.

With a presence in numerous international markets, Stentys has established partnerships with leading hospitals and healthcare systems to support enhanced patient care. The company's strengths lie in its commitment to research and development, which has led to patented technologies that differentiate its products from competitors.Stentys has also engaged in strategic mergers and acquisitions to bolster its product portfolio and enhance its global reach, ensuring that it remains competitive and well-positioned amidst the evolving demands of the surgical stent market.

Key Companies in the Surgical Stents Market Include

• MicroPort Scientific


• Stentys


• Asahi Intecc


• Teleflex


• Smith & Nephew


• Cook Medical


• R. Bard


• Biotronik


• Medtronic


• Cardinal Health


• Terumo Corporation


• Johnson & Johnson


• Lepu Medical


• Abbott Laboratories


• Boston Scientific

Surgical Stents Market Developments

By paying €760 million to acquire Biotronik's Vascular Intervention division in July 2025, Teleflex greatly increased the scope of its active treatment offering by adding a variety of interventional access solutions.A significant advancement in bioresorbable stent technology, which supports vascular healing before progressively dissolving, was made in June 2025 when StentIt reported the first-in-human implantation of their Resorbable Fibrillated Scaffold (RFS) in patients with persistent limb-threatening ischemia below the knee.

Abbott's next-generation XIENCE Sierra drug-eluting coronary stent system, which integrates AI-enabled imaging tools and improves deliverability and accuracy for difficult coronary treatments, was introduced in India in May 2024.For its Advanix biliary plastic stents, which provide improved deliverability and repositionability for the treatment of biliary strictures and cancers, Boston Scientific obtained FDA 510(k) clearance and CE Mark certification in October 2024.

The first patient implantation in a study intended to support a future FDA filing took place at Brigham and Women's Hospital in 2024 when Microbot Medical launched its key IDE clinical trial with the LIBERTY® endovascular robotic surgical system.The company's foray into low-profile covered stent solutions began in 2023 when Endovastec announced the first clinical implantations of their Castor branching aortic stent-graft and Hercules‑LP thoracic stent graft in Singapore.

Surgical Stents Market Segmentation Insights

Surgical Stents Market Product Type Outlook

• Coronary Stents


• Peripheral Stents


• Biliary Stents


• Urological Stents


• Gastrointestinal Stents

Surgical Stents Market Material Outlook

• Metal Stents


• Polymer Stents


• Bioabsorbable Stents


• Coated Stents

Surgical Stents Market End-user Outlook

• Hospitals


• Ambulatory Surgical Centers


• Specialty Clinics

Surgical Stents Market Delivery Method Outlook

• Balloon-Expandable Stents


• Self-Expanding Stents

Surgical Stents Market Regional Outlook

• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa

Report Attribute/Metric	Details
Market Size 2023	5.79(USD Billion)
Market Size 2024	6.07(USD Billion)
Market Size 2035	10.2(USD Billion)
Compound Annual Growth Rate (CAGR)	4.83% (2025 - 2035)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	MicroPort Scientific, Stentys, Asahi Intecc, Teleflex, Smith & Nephew, Cook Medical, C.R. Bard, Biotronik, Medtronic, Cardinal Health, Terumo Corporation, Johnson & Johnson, Lepu Medical, Abbott Laboratories, Boston Scientific
Segments Covered	Product Type, Material, End-user, Delivery Method, Regional
Key Market Opportunities	Rising prevalence of chronic diseases, Technological advancements in stent design, Growing geriatric population, Increased demand for minimally invasive procedures, Expansion in emerging markets
Key Market Dynamics	Increasing prevalence of chronic diseases, Growing geriatric population, Technological advancements in stenting, Rising demand for minimally invasive procedures, Regulatory approvals and compliance challenges
Countries Covered	North America, Europe, APAC, South America, MEA